Catamaran launches compound medication monitor

Catamaran Corp. (NASDAQ: CTRX) (TSX: CCT) said it has introduced its newest clinical service offering, the safe and effective compound use reassurance effort (SECURE), to help clients better monitor and manage the safety and cost-effectiveness of compound medications.

A robust menu of services aimed at addressing safety and cost concerns will be offered to all Catamaran commercial clients through SECURE, allowing them to tailor the offering to their specific needs by selecting which parameters they would like to put in place.

Catamaran, the industry´s fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs. For more information, visit CatamaranRx.com, and for industry news and information follow Catamaran on Twitter, @CatamaranCorp.

0saves
If you enjoyed this post, please consider leaving a comment or subscribing to the RSS feed to have future articles delivered to your feed reader.

Comments are closed.

Powered by WordPress